introduction | 4, 6-dioxoheptanoic acid is an organic intermediate, which can be prepared by the reaction of acetal and acetic acid, and can be used to synthesize CEP derivatives (CEP-DPPE) of 1, 2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine, it can be used for the treatment of macular degeneration. |
preparation | 4, 6-dioxoheptanoic acid (DOHA): dissolve acetal (240mg,1.2mmol) in AcOH/H2O(20mL,3:1,v/v) solution and stir for 4 hours at 50 ℃ under Ar protection. TLC(CH2Cl2/CH3OH10: 1) was used to monitor the reaction process. Once the reaction is complete, the solvent is removed by rotary evaporation to obtain crude 4,6-dioxoheptanoic acid (172.7mg,1.09mmol,91%). |
biological activity | 4,6-Dioxoheptanoic acid is an effective inhibitor of heme biosynthesis. |
target | Human Endogenous Metabolite |
in vitro research | 4, 6-Dioxohptanoic acid (Succinylacetone, SA) is examined with regard to its ability to a) inhibit the second enzyme of the heme pathway, δ-aminolevulinic acid (ALA) dehydratase, B) lower the heme concentration, and c) inhibit cell growth of murine erythroleukemia (MEL) cells in culture. |